查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830922

2025年全球病毒清除市場報告

Viral Clearance Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，病毒清除市場發展迅速，預計從2024年的8.2億美元成長到2025年的9.6億美元，複合年成長率達16.9%。這段時期的成長主要受以下因素驅動：生物製藥產量增加、監管機構對病毒安全性的日益重視、慢性病和感染疾病率上升、血漿衍生產品生產的擴張、外包給合約研究組織（CRO）和合約開發與生產組織（CDMO）的增加，以及單株抗體和重組蛋白的廣泛應用。

預計未來幾年病毒清除市場將快速成長，到2029年市場規模將達到17.7億美元，複合年成長率（CAGR）為16.6%。預測期內的成長主要受以下因素驅動：細胞和基因療法需求的成長、生物製造中對生物安全性的日益重視、更嚴格的監管驗證要求、生技藥品生產設施的擴張、病毒安全性檢測外包的增加以及生物加工中一次性系統的日益普及。這段時期的主要趨勢包括：高通量分析技術的整合、一次性系統的廣泛應用、過濾和層析法方法的進步、連續生物加工的興起以及合約研究和生產服務的成長。

病毒清除是指檢測、移除和惰性生物製品中的病毒，以確保其不含病毒污染的過程。該過程包括過濾、化學處理和熱惰性等步驟，其主要目標是透過最大限度地降低病毒感染風險來確保產品的安全性和純度。

病毒清除的主要方法包括病毒去除、病毒惰性和病毒檢測。這些技術旨在去除生物製品中潛在的病毒污染物。這些技術應用於多個領域，包括疫苗和治療藥物、血液和血液製品、細胞和基因治療產品以及組織和組織製品，服務於製藥和生物技術公司、受託研究機構(CRO) 以及學術研究機構等終端用戶。

2025年，美國關稅的突然上調及其引發的貿易摩擦對製藥公司造成了嚴重衝擊。利潤豐厚的學名藥生產商尤其脆弱，一些公司不得不縮減低利潤藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供病毒清除市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和機遇，以及您在市場中取得成功所需的各種數據。本市場研究報告對行業現狀和未來發展趨勢進行了深入分析，為您提供所需的一切全面觀點。

預計未來幾年，慢性病盛行率的不斷上升將推動病毒清除市場的成長。慢性病是指需要持續照護和管理的長期健康狀況。隨著醫療保健和生活水準的提高，人們的壽命越來越長，心血管疾病、糖尿病、關節炎和癌症等與老齡化相關的疾病的發病率和盛行率在全球範圍內不斷上升。病毒清除在用於治療慢性病的生技藥品和基因療法藥物的研發中發揮關鍵作用，確保這些療法的安全性和有效性。例如，總部位於美國的公共衛生研究機構－健康指標與評估研究所（IHME）在2023年6月發布的報告顯示，全球有超過5億人患有糖尿病，並預測2050年這一數字將超過13億人。因此，慢性病的增加正在推動對病毒清除市場的需求。

為了滿足日益成長的基因治療藥物和生技藥品需求，病毒清除市場的企業正日益重視產能擴大策略，例如建造大規模病毒載體生產設施。大規模病毒載體生產設施是先進的生物生產基地，用於生產細胞和基因療法中使用的病毒載體，確保產品的高純度、安全性和符合病毒清除標準。例如，2022年8月，美國生技公司賽默飛世爾科技（Thermo Fisher Scientific）在麻薩諸塞州普萊恩維爾開設了一座佔地30萬平方英尺的商業病毒載體生產設施。該設施使該公司的全球產能加倍，並支持包括病毒清除和分析檢測在內的端到端生產流程，從而實現基因療法、疫苗和先進生技藥品的快速安全商業化。

2024年8月，總部位於德國的醫療保健公司默克集團以6億美元收購了Mirus Bio LLC。透過此次收購，默克整合了Mirus Bio的尖端轉染技術，增強了其病毒載體生產能力，從而更好地為不斷成長的基因治療市場提供一體化解決方案。總部位於美國的Mirus Bio LLC專注於病毒清除過程中使用的轉染試劑。

病毒清除市場由提供病毒清除和惰性測試、驗證測試以及法規諮詢等服務的營業單位所獲得的收入構成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關商品的價值。病毒清除市場還包括病毒過濾器、試劑和專用清除設備的銷售。該市場的價值為“出廠價”，即商品製造商或創造者銷售的商​​品價值，無論銷售對像是其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場中的商品價值也包括商品創造者提供的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球病毒清除：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球病毒清除市場：成長率分析
  • 全球病毒清除市場表現：規模與成長，2019-2024年
  • 全球病毒清除市場預測：規模與成長，2024-2029年，2034年
  • 全球病毒清除：潛在市場規模 (TAM)

第6章 市場細分

  • 全球病毒清除市場依方法、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 病毒清除
  • 病毒清除
  • 病毒去活化
  • 病毒檢測
  • 全球病毒清除市場依應用、效能及預測分類，2019-2024年、2024-2029年、2034年
  • 疫苗和治療
  • 血液和血液製品
  • 細胞和基因療法產品
  • 組織/組織產品
  • 其他
  • 全球病毒清除市場依最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 製藥和生物技術公司
  • CRO（受託研究機構）
  • 學術研究機構
  • 其他
  • 全球病毒清除市場：病毒清除細分市場，按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 下游加工
  • 過濾
  • 層析法
  • 沉澱
  • 奈米過濾
  • 全球病毒清除市場：病毒清除細分市場（按類型分類）、實際數據及預測（2019-2024年、2024-2029年、2034年）
  • 膜層析法
  • 深度過濾
  • 奈米過濾
  • 超過濾
  • 蛋白A親和層析法
  • 全球病毒清除市場：病毒去活化細分市場，按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 溶劑清潔劑法
  • 低pH值處理
  • 熱處理（巴氏殺菌）
  • 紫外線C波段照射
  • 辛酸治療
  • 全球病毒清除市場：病毒檢測細分、按類型、效能和預測分類（2019-2024年、2024-2029年、2034年）
  • PCR（聚合酵素鏈鎖反應）
  • ELISA（酵素免疫分析法試驗）
  • 核酸檢測（NAT）
  • 基於細胞的檢測
  • 穿透式電子顯微鏡（TEM）

第7章 區域和國家分析

  • 全球病毒清除市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
  • 全球病毒清除市場：依國家、績效及預測分類，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 病毒清除市場：競爭格局
  • 病毒清除市場：公司概況
    • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • SGS SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Eurofins Scientific Inc.
  • Lonza Group AG
  • WuXi AppTec
  • Catalent Biologics
  • Charles River Laboratories
  • Kedrion Biopharma
  • Nelson Labs
  • Pall Corporation
  • Sartorius AG
  • Syngene International
  • Microbac Laboratories
  • Creative Biolabs
  • Texcell SA
  • GTP Bioways
  • Vironova AB

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年病毒清除市場：提供新機會的國家
  • 病毒清除市場展望 2029：新興細分市場帶來新機會
  • 病毒清除市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37915

Viral clearance is the process of detecting, removing, or inactivating viruses from biological products to ensure they are free from viral contamination. This involves steps such as filtration, chemical treatment, or heat inactivation, with the primary goal of ensuring product safety and purity by minimizing the risk of viral transmission.

The primary approaches to viral clearance include viral removal, viral inactivation, and viral detection. These techniques are designed to eliminate potential viral contaminants from biological products. They are applied across various areas, including vaccines and therapeutics, blood and blood products, cellular and gene therapy products, and tissue-based products, serving end users such as pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The viral clearance market research report is one of a series of new reports from The Business Research Company that provides viral clearance market statistics, including the viral clearance industry's global market size, regional shares, competitors with the viral clearance market share, detailed viral clearance market segments, market trends and opportunities, and any further data you may need to thrive in the viral clearance market. This viral clearance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral clearance market size has grown rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be credited to the increase in biopharmaceutical production, heightened regulatory focus on viral safety, rising prevalence of chronic and infectious diseases, expansion in plasma-derived product manufacturing, growing outsourcing to CROs and CDMOs, and broader adoption of monoclonal antibodies and recombinant proteins.

The viral clearance market size is expected to see rapid growth in the next few years. It will grow to $1.77 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for cell and gene therapies, heightened focus on biosafety in biomanufacturing, more stringent regulatory validation requirements, expansion of biologics production facilities, rising outsourcing of viral safety testing, and greater adoption of single-use systems in bioprocessing. Major trends during this period include the integration of high-throughput analytical technologies, widespread adoption of single-use systems, advancements in filtration and chromatography methods, progress in continuous bioprocessing, and growth in contract research and manufacturing services.

The increasing prevalence of chronic diseases is expected to drive growth in the viral clearance market in the coming years. Chronic diseases are long-term health conditions that develop over time and often require ongoing care or management. Their prevalence is rising globally, largely due to aging populations, as improvements in healthcare and living standards allow people to live longer, resulting in a higher incidence of age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance plays a critical role in the development of biologics and gene therapies for treating chronic diseases, ensuring these treatments are safe and effective. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to exceed 1.3 billion by 2050. Thus, the rising prevalence of chronic diseases is fueling demand in the viral clearance market.

Companies in the viral clearance market are increasingly focusing on capacity expansion strategies, such as large-scale viral vector manufacturing facilities, to meet the growing demand for gene therapies and biologics. Large-scale viral vector manufacturing facilities are advanced bioproduction sites equipped to produce viral vectors used in cell and gene therapies, ensuring high purity, safety, and adherence to viral clearance standards. For instance, in August 2022, Thermo Fisher Scientific, a US-based biotechnology company, opened a 300,000-square-foot commercial viral vector manufacturing facility in Plainville, Massachusetts. This facility doubles the company's global capacity, supports end-to-end manufacturing including viral clearance and analytical testing, and enables the rapid, safe commercialization of gene therapies, vaccines, and advanced biologics.

In August 2024, Merck Group, a Germany-based healthcare company, acquired Mirus Bio LLC for $600 million. This acquisition strengthens Merck's viral vector manufacturing capabilities by incorporating Mirus Bio's leading transfection technology, enhancing its ability to provide integrated solutions for the growing gene therapy market. Mirus Bio LLC, based in the US, specializes in transfection reagents used in viral clearance processes.

Major players in the viral clearance market are F Hoffmann-La Roche Ltd., Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Kedrion Biopharma, Nelson Labs, Pall Corporation, Sartorius AG, Syngene International, Microbac Laboratories, Creative Biolabs, Texcell SA, GTP Bioways, and Vironova AB.

North America was the largest region in the viral clearance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral clearance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral clearance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral clearance market consists of revenues earned by entities by providing services such as viral removal and inactivation testing, validation studies, and regulatory consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral clearance market also includes sales of viral filters, reagents, and specialized clearance equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Clearance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral clearance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral clearance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral clearance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Method: Viral Clearance Method; Viral Removal Method; Viral Inactivation Method; Viral Detection Method
  • 2) By Application: Vaccines And Therapeutics; Blood And Blood Products; Cellular And Gene Therapy Products; Tissue And Tissue Products; Other Applications
  • 3) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic Research Institutes; Other End Users
  • Subsegments:
  • 1) By Viral Clearance Method: Downstream Processing; Filtration; Chromatography; Precipitation; Nanofiltration
  • 2) By Viral Removal Method: Membrane Chromatography; Depth Filtration; Nanofiltration; Ultrafiltration; Protein A Affinity Chromatography
  • 3) By Viral Inactivation Method: Solvent Detergent Method; Low pH Treatment; Heat Treatment (Pasteurization); UV-C Irradiation; Caprylate Treatment
  • 4) By Viral Detection Method: PCR (Polymerase Chain Reaction); ELISA (Enzyme-Linked Immunosorbent Assay); Nucleic Acid Testing (NAT); Cell-Based Assays; Transmission Electron Microscopy (TEM)
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Merck Group; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; SGS SA; Eurofins Scientific Inc.; Lonza Group AG; WuXi AppTec; Catalent Biologics; Charles River Laboratories; Kedrion Biopharma; Nelson Labs; Pall Corporation; Sartorius AG; Syngene International; Microbac Laboratories; Creative Biolabs; Texcell SA; GTP Bioways; Vironova AB.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Clearance Market Characteristics

3. Viral Clearance Market Trends And Strategies

4. Viral Clearance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Clearance Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Viral Clearance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Viral Clearance Market Growth Rate Analysis
  • 5.4. Global Viral Clearance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Viral Clearance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Viral Clearance Total Addressable Market (TAM)

6. Viral Clearance Market Segmentation

  • 6.1. Global Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Viral Clearance Method
  • Viral Removal Method
  • Viral Inactivation Method
  • Viral Detection Method
  • 6.2. Global Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccines And Therapeutics
  • Blood And Blood Products
  • Cellular And Gene Therapy Products
  • Tissue And Tissue Products
  • Other Applications
  • 6.3. Global Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Other End Users
  • 6.4. Global Viral Clearance Market, Sub-Segmentation Of Viral Clearance Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Downstream Processing
  • Filtration
  • Chromatography
  • Precipitation
  • Nanofiltration
  • 6.5. Global Viral Clearance Market, Sub-Segmentation Of Viral Removal Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Membrane Chromatography
  • Depth Filtration
  • Nanofiltration
  • Ultrafiltration
  • Protein A Affinity Chromatography
  • 6.6. Global Viral Clearance Market, Sub-Segmentation Of Viral Inactivation Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solvent Detergent Method
  • Low pH Treatment
  • Heat Treatment (Pasteurization)
  • UV-C Irradiation
  • Caprylate Treatment
  • 6.7. Global Viral Clearance Market, Sub-Segmentation Of Viral Detection Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Nucleic Acid Testing (NAT)
  • Cell-Based Assays
  • Transmission Electron Microscopy (TEM

7. Viral Clearance Market Regional And Country Analysis

  • 7.1. Global Viral Clearance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Viral Clearance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Clearance Market

  • 8.1. Asia-Pacific Viral Clearance Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Clearance Market

  • 9.1. China Viral Clearance Market Overview
  • 9.2. China Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Clearance Market

  • 10.1. India Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Clearance Market

  • 11.1. Japan Viral Clearance Market Overview
  • 11.2. Japan Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Clearance Market

  • 12.1. Australia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Clearance Market

  • 13.1. Indonesia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Clearance Market

  • 14.1. South Korea Viral Clearance Market Overview
  • 14.2. South Korea Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Clearance Market

  • 15.1. Western Europe Viral Clearance Market Overview
  • 15.2. Western Europe Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Clearance Market

  • 16.1. UK Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Clearance Market

  • 17.1. Germany Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Clearance Market

  • 18.1. France Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Clearance Market

  • 19.1. Italy Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Clearance Market

  • 20.1. Spain Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Clearance Market

  • 21.1. Eastern Europe Viral Clearance Market Overview
  • 21.2. Eastern Europe Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Clearance Market

  • 22.1. Russia Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Clearance Market

  • 23.1. North America Viral Clearance Market Overview
  • 23.2. North America Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Clearance Market

  • 24.1. USA Viral Clearance Market Overview
  • 24.2. USA Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Clearance Market

  • 25.1. Canada Viral Clearance Market Overview
  • 25.2. Canada Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Clearance Market

  • 26.1. South America Viral Clearance Market Overview
  • 26.2. South America Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Clearance Market

  • 27.1. Brazil Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Clearance Market

  • 28.1. Middle East Viral Clearance Market Overview
  • 28.2. Middle East Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Clearance Market

  • 29.1. Africa Viral Clearance Market Overview
  • 29.2. Africa Viral Clearance Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Viral Clearance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Viral Clearance Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Clearance Market Competitive Landscape And Company Profiles

  • 30.1. Viral Clearance Market Competitive Landscape
  • 30.2. Viral Clearance Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Viral Clearance Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific Inc.
  • 31.2. Lonza Group AG
  • 31.3. WuXi AppTec
  • 31.4. Catalent Biologics
  • 31.5. Charles River Laboratories
  • 31.6. Kedrion Biopharma
  • 31.7. Nelson Labs
  • 31.8. Pall Corporation
  • 31.9. Sartorius AG
  • 31.10. Syngene International
  • 31.11. Microbac Laboratories
  • 31.12. Creative Biolabs
  • 31.13. Texcell SA
  • 31.14. GTP Bioways
  • 31.15. Vironova AB

32. Global Viral Clearance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Clearance Market

34. Recent Developments In The Viral Clearance Market

35. Viral Clearance Market High Potential Countries, Segments and Strategies

  • 35.1 Viral Clearance Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Viral Clearance Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Viral Clearance Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer